|
|
Volumn 315, Issue 19, 2016, Pages 2069-2070
|
|
Utility of cancer value frameworks for patients, payers, and physicians
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER PATIENT;
CANCER SURGERY;
CANCER SURVIVAL;
CANCER THERAPY;
CLINICAL EFFECTIVENESS;
CONCEPTUAL FRAMEWORK;
EVIDENCE BASED MEDICINE;
FINANCIAL MANAGEMENT;
HEALTH CARE COST;
HOSPITAL COST;
HOSPITALIZATION;
HUMAN;
MEDICAL CARE;
MEDICAL SOCIETY;
MULTIPLE MYELOMA;
NOTE;
OBSERVATIONAL STUDY;
ONCOLOGY;
OVERALL SURVIVAL;
PATIENT CARE;
PATIENT SAFETY;
PRIORITY JOURNAL;
QUALITY OF LIFE;
COST BENEFIT ANALYSIS;
DISEASE FREE SURVIVAL;
ECONOMICS;
NEOPLASMS;
ORGANIZATION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REIMBURSEMENT;
STANDARDS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
COST-BENEFIT ANALYSIS;
DISEASE-FREE SURVIVAL;
FINANCING, PERSONAL;
HEALTH CARE COSTS;
HUMANS;
INSURANCE, HEALTH, REIMBURSEMENT;
NEOPLASMS;
ORGANIZATIONS;
OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);
PATIENT SAFETY;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SURVIVAL ANALYSIS;
|
|
EID: 84969195206
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2016.4915 Document Type: Note |
|
Times cited : (53)
|
|
References (8)
|
